olmesartan has been researched along with Obesity in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 11 (55.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawkins, C; Kieu, Z; Kitazawa, M; Maitra, N; Mejias-Ortega, M; Nishiyama, A; Ortiz, RM; Peng, M; Rodriguez, R; Rodriguez-Ortiz, CJ; Thorwald, MA; Valenzuela, J | 1 |
| Batista, GMS; Campos, MO; Garcia, VP; Gomes, EAC; Mentzinger, J; Nóbrega, ACL; Rocha, HNM; Rocha, NG; Storch, AS; Teixeira, GF | 1 |
| Bazylevych, AY; Bochar, OM; Bochar, VT; Faynyk, AF; Kuzminov, YB; Sklyarova, HY | 1 |
| Lam, L; Nakano, D; Nishiyama, A; Ortiz, RM; Peti-Peterdi, J; Popovich, I; Rodriguez, R; Sonanez-Organis, JG; Thorwald, MA; Vázquez-Medina, JP; Viscarra, JA | 1 |
| Cheng, XW; Dai, Q; Hao, C; Murohara, T; Wu, H; Yao, H; Zhang, Z | 1 |
| Ammentorp, B; de la Sierra, A; Kreutz, R; Laeis, P | 1 |
| Anderson, AS; Boutagy, NE; Davy, BM; Davy, KP; Frisard, MI; Hulver, MW; Marinik, EL; McMillan, RP; Rivero, JM | 1 |
| Dong, YF; Ichijo, H; Kataoka, K; Kim-Mitsuyama, S; Matsuba, S; Ogawa, H; Tokutomi, Y; Yamamoto, E; Yamashita, T | 1 |
| Feng, Q; Guo, J; Lao, GC; Liu, W; Ran, JM; Xie, B; Xu, G; Zhang, Y | 1 |
| Chrysant, SG; Heyrman, R; Karki, S; Lee, J; Melino, M | 1 |
| Makris, T; Stefanadis, C; Thomopoulos, C; Tsioufis, C | 1 |
| Aller, R; Castro, MJ; Conde, R; De Luis, DA; Gonzalez Sagrado, M; Izaola, O; Perez Castrillon, JL; Romero, E | 1 |
| Maa, JF; Punzi, H; Shojaee, A; Waverczak, WF | 1 |
| Biskupiak, J; Qian, C; Quah, R; Ram, CV; Ramaswamy, K; Russo, PA; Ryan, A | 1 |
| Goto, SN; Mizuno, Y; Takagi, H; Umemoto, T; Yamamoto, H | 1 |
| Davy, BM; Davy, KP; Frisard, MI; Hulver, MW; Marinik, EL; Rivero, JM; Savla, JS | 1 |
| Hirata, A; Igarashi, M; Kadomoto-Antsuki, Y; Nozaki, H; Tominaga, M | 1 |
| Fujita, K; Funahashi, T; Hibuse, T; Hiuge, A; Kihara, S; Kumada, M; Kurata, A; Kuriyama, H; Maeda, N; Nishizawa, H; Ohashi, K; Okada, T; Shimomura, I; Sonoda, M; Yasui, A | 1 |
| Haruna, Y; Kashihara, N; Kobayashi, S; Komai, N; Namikoshi, T; Sasaki, T; Satoh, M; Tomita, N | 1 |
| Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
1 review(s) available for olmesartan and Obesity
| Article | Year |
|---|---|
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Hypertension, Renal; Imidazoles; Interleukin-6; Obesity; Prospective Studies; Publication Bias; Randomized Controlled Trials as Topic; Stents; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2013 |
6 trial(s) available for olmesartan and Obesity
| Article | Year |
|---|---|
Efficacy and tolerability of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide: a subgroup analysis of patients stratified by hypertension severity, age, sex, and obesity.
Topics: Adult; Age Factors; Aged; Amlodipine; Blood Pressure; Body Mass Index; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Sex Factors; Tetrazoles | 2014 |
Angiotensin II receptor blockade and skeletal muscle metabolism in overweight and obese adults with elevated blood pressure.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Body Mass Index; Fatty Acids; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Muscle, Skeletal; Obesity; Tetrazoles; Young Adult | 2015 |
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension.
Topics: Age Factors; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Black or African American; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Risk Assessment; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; United States; Vasodilator Agents | 2010 |
Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Mass Index; Body Weight; Cholesterol; Cytokines; Female; Humans; Hypertension; Imidazoles; Insulin; Irbesartan; Middle Aged; Nicotinamide Phosphoribosyltransferase; Obesity; Prospective Studies; Spain; Tetrazoles; Time Factors; Treatment Outcome; Triglycerides | 2010 |
Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure.
Topics: Angiotensin Receptor Antagonists; Biopsy; Cross-Over Studies; Female; Glucose Tolerance Test; Humans; Hypertension; Imidazoles; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Obesity; Overweight; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2013 |
Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Female; Fibrinogen; Glucose Clamp Technique; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Indans; Insulin Resistance; Male; Middle Aged; Nitrobenzenes; Obesity; Piperazines; Tetrazoles | 2008 |
13 other study(ies) available for olmesartan and Obesity
| Article | Year |
|---|---|
Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Brain; Diabetes Mellitus, Type 2; Metabolic Syndrome; Obesity; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Receptors, Angiotensin | 2023 |
AT1R blocker prevents mental stress induced retrograde blood flow in overweight/obese men.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Brachial Artery; Endothelium, Vascular; Humans; Male; Nitrites; Obesity; Overweight; Regional Blood Flow; Stress, Psychological; Vasodilation; Young Adult | 2023 |
The effect of therapy with olmesartan or telmisartan in patients with arterial hypertension combined with obesity.
Topics: Blood Pressure; Humans; Hypertension; Imidazoles; Obesity; Telmisartan; Tetrazoles | 2020 |
Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats.
Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Catalase; Citrate (si)-Synthase; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; Imidazoles; Insulin Resistance; Male; Membrane Glycoproteins; Mitochondria, Heart; Myocardium; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; NF-E2-Related Factor 2; Obesity; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Inbred OLETF; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Succinate Dehydrogenase; Superoxide Dismutase; Tetrazoles; Time Factors; Tyrosine | 2013 |
Regulation of apelin and its receptor expression in adipose tissues of obesity rats with hypertension and cultured 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apelin; Apelin Receptors; Gene Expression; Gene Expression Regulation; Hypertension; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Obesity; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Tetrazoles | 2014 |
Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Eating; Endothelium, Vascular; Fatty Liver; Fibrosis; Imidazoles; Insulin Resistance; Male; MAP Kinase Kinase Kinase 5; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; NADPH Oxidases; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Obesity; Reactive Oxygen Species; Signal Transduction; Tetrazoles; Transforming Growth Factor beta1 | 2008 |
[Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Cholesterol; Fatty Acids, Nonesterified; Imidazoles; Lipid Metabolism; Liver; Male; Obesity; Rats; Rats, Zucker; Tetrazoles; Triglycerides | 2008 |
Pharmacological therapy for hypertensive children: an "additional bypass" of lifestyle interventions.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Child; Humans; Hypertension; Imidazoles; Life Style; Obesity; Safety; Tetrazoles | 2010 |
Efficacy of amlodipine and olmesartan medoxomil in hypertensive patients with diabetes and obesity.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Obesity; Prospective Studies; Tetrazoles | 2011 |
Blood pressure outcomes in patients receiving angiotensin II receptor blockers in primary care: a comparative effectiveness analysis from electronic medical record data.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Black or African American; Blood Pressure; Diabetes Mellitus; Electronic Health Records; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Obesity; Primary Health Care; Retrospective Studies; Tetrazoles; Treatment Outcome; Valine; Valsartan; White People; Young Adult | 2011 |
Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Aorta; Blood Glucose; Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Experimental; DNA Replication; Imidazoles; Male; Muscle, Smooth, Vascular; Nuclear Proteins; Obesity; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 2007 |
Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Cells, Cultured; Female; Gene Expression Regulation; Imidazoles; Kidney Diseases; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Oxidative Stress; Plasminogen Activator Inhibitor 1; Reactive Oxygen Species; RNA, Messenger; Serum Amyloid A Protein; Signal Transduction; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein.
Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Dietary Proteins; Disease Models, Animal; Endothelium, Vascular; Hydralazine; Hypertension, Renovascular; Imidazoles; Kidney; Male; Metabolic Syndrome; NADPH Oxidases; Obesity; Oxidative Stress; Rats; Rats, Zucker; Tetrazoles | 2007 |